Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Myopia control effect of Defocus Incorporated Multiple Segments lenses in an Indian population with progressive myopia
Author Affiliations & Notes
  • Shruti Nishanth
    Paediatric Ophthalmology, Maastricht Universitair Medisch Centrum+, Maastricht, Limburg, Netherlands
    Paediatric Ophthalmology, MN Eye Hospital Private Ltd, Chennai, Tamil Nadu, India
  • Arockia Agila
    Paediatric Ophthalmology, MN Eye Hospital Private Ltd, Chennai, Tamil Nadu, India
  • Maheswari Srinivasan
    Paediatric Ophthalmology, MN Eye Hospital Private Ltd, Chennai, Tamil Nadu, India
  • Nivean madhivanan
    Paediatric Ophthalmology, MN Eye Hospital Private Ltd, Chennai, Tamil Nadu, India
  • Rakhee Shah
    Optometry & Visual Sciences, University of London, United Kingdom
    Hoya Kabushiki Kaisha, Amsterdam, Netherlands
  • Footnotes
    Commercial Relationships   Shruti Nishanth None; Arockia Agila None; Maheswari Srinivasan None; Nivean madhivanan None; Rakhee Shah Hoya, Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2738. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shruti Nishanth, Arockia Agila, Maheswari Srinivasan, Nivean madhivanan, Rakhee Shah; Myopia control effect of Defocus Incorporated Multiple Segments lenses in an Indian population with progressive myopia. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2738.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Defocus Incorporated Multiple Segments (DIMS) spectacle lenses have proven efficacy in inhibiting myopia progression with several published studies in different populations. There is a dearth of literature on the effectiveness of DIMS lenses from the Indian subcontinent. We conducted a prospective study to evaluate myopia progression during a 6-month period before and a 1-year period after the utilization of DIMS lenses.

Methods : In this 18-month study, 50 children (100 eyes), aged 7 to 17 years, with cycloplegic refraction between -1.00 D to -9.00 D and astigmatism ≤-1.50D, progressive myopia of ≥-0.5D in the preceding 6 months, and no history of previous myopia control strategies, were included. At diagnosis, all children were prescribed single-vision spectacles and monitored for 6 months for documented myopic progression. DIMS lenses were prescribed to 25 children (self-selected) at this visit (V1), and the children were monitored at 6 months (V2) and 12 months (V3). A self-selected, age-matched control group of 25 children was also monitored with single vision glasses for the same period. Refractive error (cycloplegic autorefraction) using NIDEK ARK -510A and axial length (AL) using NIDEK AL scan were measured at each visit.

Results : The mean age was 10.8 ± 4 years. The mean baseline spherical equivalent refraction (SER) was -4.2D ± 1.9D, mean AL was 24.9 ± 0.9 mm. The mean SER progression from baseline to V1 visit was -0.8 ± 0.4D, V1 to V2 was -0.16 ±0.2D and V1 to V3 was -0.24D ±0.2D. The mean AL change from baseline to V1 visit was 0.33 ± 0.1 mm, from V1 to V2 was 0.07±0.1 mm and V1 to V3 was 0.13± 0.1mm. At 6 months, 50% of eyes had no SER progression, and 94.4% of eyes showed progression of < -0.50D. At 12 months, 32% of eyes had no SER progression and 94% of eyes showed progression of <-0.50D. At 12 months, 42% of eyes had axial length change < 0.1 mm. The difference in SER for the controls over 1 year was -0.7 ± 0.5D with mean axial length elongation of 0.3±0.1 mm. The DIMS group had significantly less SER progression and AL elongation (p<0.001) than the control group.

Conclusions : DIMS spectacle lenses are effective in slowing myopia progression in an Indian population with documented progressive myopia. Our study showed better control at 6 months compared to 12 months. Future long-term studies are required to study the effects of DIMS on Indian children.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×